Related Experiment Videos
Bleomycin-induced lung injury is enhanced by interferon-alpha
N Berkman1, R H Goldstein, R Breuer
1Pulmonary Cellular and Molecular Biology Laboratory, Institute of Pulmonology, Hadassah University Hospital and the Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Life Sciences
|January 1, 1997
Summary
Human recombinant interferon-2alpha (IFN-alpha) worsened Bleomycin-induced lung injury in hamsters. Low-dose IFN-alpha significantly augmented injury, while high-dose showed a complex, non-dose-dependent effect on pulmonary damage.
Area of Science:
- Pulmonary Medicine
- Immunology
- Toxicology
Background:
- Bleomycin (Bleo) is a chemotherapeutic agent known to cause pulmonary fibrosis.
- Interferon-alpha (IFN-alpha) is a cytokine with immunomodulatory properties.
- The interaction between IFN-alpha and Bleo-induced lung injury requires further investigation.
Purpose of the Study:
- To evaluate the effect of human recombinant interferon-2alpha (IFN-alpha) on Bleomycin (Bleo)-induced pulmonary injury in a hamster model.
- To determine if IFN-alpha modulates the severity of Bleo-induced lung damage.
Main Methods:
- Male Syrian hamsters received intratracheal (I.T.) Bleomycin or saline.
- Animals were treated with daily intraperitoneal (I.P.) injections of low-dose IFN-alpha, high-dose IFN-alpha, or saline.
- Lung injury was assessed histologically and biochemically 28 days post-treatment.
Main Results:
- Low-dose IFN-alpha significantly augmented Bleo-induced lung injury, as indicated by a morphological index.
- Lung hydroxyproline levels, a marker of fibrosis, were highest in the Bleo-low-dose-IFN-alpha group.
- High-dose IFN-alpha also increased hydroxyproline levels compared to Bleo-Saline, but the overall effect was complex and not dose-dependent.
Conclusions:
- IFN-alpha can augment Bleomycin-induced lung injury in hamsters.
- The augmentation of lung injury by IFN-alpha does not follow a simple dose-response relationship.
- These findings highlight a complex interaction between IFN-alpha and Bleo-induced pulmonary toxicity.